The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index, and 1 are not checked yet.
Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer
Open accessAbstract
Background: Urothelial bladder cancer (UBC) is a highly prevalent disease in North America, however its optimal management remains elusive. The contribution of B cell associated responses is poorly understood in bladder cancer. Lymphoid neogenesis is a hallmark of an active immune response at tumor sites that sometimes leads to formation of tertiary lymphoid structures (TLS) that resemble germinal centers formed in secondary lymphoid organs. Objective: This study was conducted with an aim to investigate the presence and characteristics of TLS in UBC with a focus to compare and contrast the TLS formation in treatment naive low grade non-muscle invasive (NMIBC) and muscle invasive bladder cancers (MIBC). Methods: The study cohort consisted of transurethral bladder resection tumour (TURBT) specimens from 28 patients. Sections showing lymphoid aggregates in hematoxylin and eosin (H&E) stained TURBT specimens were further subjected to multi-color immunohistochemistry using immune cell markers specific to CD20 + B cells, CD3 + and CD8 + T cells, PNAd + high endothelial venules, CD208 + mature dendritic cells, CD21 + follicular dendritic cells to confirm the hallmarks of classical germinal centers. Results: Our pilot study investigating the presence of TLS in bladder cancer patients is the first to demonstrate that well-formed TLS are more common in aggressive high grade MIBC tumors compared to low grade NIMBC. Conclusions: These novel findings suggest B cell mediated anti-tumour humoral immune responses in bladder cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig.1 Developmental continuum of TLS in bladder tumours. Multi-color IHC performed on 5 μm thick sections from formalin fixed paraffin embedded bladder tumour tissue to reveal features associated with the TLS architecture. Different Types of aggregates and immune cell distributions were defined as previously described by Kroeger et al., [20], A) Type I B) Type 2 C) Type 3 and D) Type 4 aggregates. E) Well formed tertiary lymphoid structure in high grade muscle invasive bladder tumour showing CD3+ (green) and CD8+ T lymphocytes (purple), CD20+ B lymphocytes (pink), CD21+ follicular dendritic cells (blue), CD208+ mature dendritic cells (black), PNAd+ high endothelial venule (brown).](https://figures.cochat.ai/paper-figures/b922a8a9ffbf4dde981431cda12b46e8/tertiary-lymphoid-structures-associate-with-tumour-stage-in-urothelial-bladder-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tertiary lymphoid structures (TLS) have recently emerged as biomarkers of response to ICT across several tumor types, including lung cancer, melanoma, RCC, sarcoma, and urothelial cancer (163-167).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [165]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474 · cited 1×
“Significant efforts in cancer immunology have been directed towards the association of tumour infiltrating lymphocytes (TILs) with disease prognosis, a feature that is of both prognostic and predictive relevance across cancers [4, 5].”
BackgroundSpatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Global Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360
Dynamics of B cells in germinal centres
De Silva, N. S., & Klein, U. (2015) · Nature Reviews Immunology · doi:10.1038/nri3804 · Cited by 1,084
Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles
Bastani, R., Glenn, B. A., & Maxwell, A. E. (2015) · eCite Digital Repository (University of Tasmania) · doi:10.1158/1055-9965 · Cited by 901
Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833
Lymphoid organ development: from ontogeny to neogenesis
Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006) · Nature Immunology · doi:10.1038/ni1330 · Cited by 776
Ectopic lymphoid-like structures in infection, cancer and autoimmunity
Pitzalis, C., Jones, G. W., Bombardieri, M., & Jones, S. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3700 · Cited by 698
Research works printed but not linked: 16
- Babjuk M, 2012, Actas Urol EsServicio de Urologia, Hospital Motol, Segunda Facultad de Medicina, Universidad Carolina, Praga, Republica Checa. Marek.badjuk@ lfmotol.cuni.cz: AEU. Published by Elsevier Espana, 36, 389
- Lima L, 2012, Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-072 Porto, Portugal, 2012, 232609
- Schreiber RD, 2011, Science. Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. schreiber@immunology.wustl.edu, 331, 1565
- Galon J, 2014, J Pathol. INSERM, U872, Laboratory of Integrative Cancer Immunology, Paris, France; Universite Paris Descartes, Paris, France; Centre de Recherche des Cordeliers, Universite Pierre et Marie Curie Paris 6, France.: The Authors. Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland, 232, 199
- Galon J, 2016, J Transl Med [Internet]. BioMed Central, 1
- Kyi C, 2014, Published by Elsevier B.V, 588, 368
- 10.1038/nri3804 · DOI · Paper page
- Dieu-Nosjean MC, 2014, Trends Immunol. Laboratory “Cancer, Immune Control and Escape”, INSERM U1138 Cordeliers Research Centre, Paris, France; University Pierre and Marie Curie, UMRS 1138, Paris, France; University Paris Descartes, UMRS 1138, Paris, France.; Laboratory ’Cancer, Immune Control: Elsevier Ltd, 35, 571
- Coppola D, 2011, Am J Pathol. Anatomic Pathology Division, Moffitt Cancer Center, Tampa, FL 33612-9497, USA.: American Society for Investigative Pathology. Published by Elsevier Inc, 179, 37
- Dieu-Nosjean MC, 2008, J Clin Oncol. Laboratoire Microenvironnement, Immunitaire et Tumeurs, Institut National de la Sante et de la Recherche Medicale (INSERM) U872, Centre de Recherche des Cordeliers, Paris cedex 06, France. mc.dieu-nosjean@crc.jussieu.fr, 26, 4410
- Martinet L, 2011, Cancer Res. CNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), INSERM, U563, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France.: AACR, 71, 5678
- Pitzalis C, 2014, Nat Rev. Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London, School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.; Cardiff Institute for Infection and I, 14, 447
- Finkin S, 2015, Nat Immunol [Internet]. Nature Publishing Group, 1
- Nielsen JS, 2012, Clin Cancer Res. Trev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada. jnielsen@bccancer.bc.ca: AACR, 18, 3281
- Matsumoto H, 2015, J Clin Pathol. Department of Pathology, Singapore General Hospital, Singapore, Singapore Department of Pathology, Ryukyu University Hospital, Okinawa, Japan.; Department of Medical Oncology, National Cancer Centre, Singapore, Singapore.; Department of Medical Oncology;
- Quinn DI, 2015, Urol Oncol. Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer, Los Angeles, CA.Carolina Urologic Research Center, Myrtle Beach, SC.; Department of Urology, Jikei University School of Med: The Authors. Published by Elsevier Inc
Cited by
Tertiary lymphoid structures in the era of cancer immunotherapy
Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0144-6 · Cited by 1,884
The Next Decade of Immune Checkpoint Therapy
Sharma, P., Siddiqui, B. A., Anandhan, S., Yadav, S. S., Subudhi, S. K., Gao, J., Goswami, S., & Allison, J. P. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1680 · Cited by 750
Extensive heterogeneity in somatic mutation and selection in the human bladder
Lawson, A. R. J., Abascal, F., Coorens, T. H. H., Hooks, Y., O’Neill, L., Latimer, C., Raine, K., Sanders, M. A., Warren, A. Y., Mahbubani, K. T. A., et al. (2020) · Science · doi:10.1126/science.aba8347 · Cited by 311
High endothelial venules (HEVs) in immunity, inflammation and cancer
Blanchard, L., & Girard, J.-P. (2021) · Angiogenesis · doi:10.1007/s10456-021-09792-8 · Cited by 207
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer
Sofopoulos, M., Fortis, S. P., Vaxevanis, C. K., Sotiriadou, N. N., Arnogiannaki, N., Ardavanis, A., Vlachodimitropoulos, D., Perez, S. A., & Baxevanis, C. N. (2019) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-019-02407-8 · Cited by 160
Metadata
- Authors
- Koti, M., Xu, A. S., Ren, K. Y. M., Visram, K., Ren, R., Berman, D. M., & Siemens, D. R.
- Affiliations
- Queen's University (CA)
- Corresponding author
- Koti, Madhuri
- Venue
- Bladder Cancer
- Publisher
- SAGE Publications
- Published
- 2017-10-27
- Volume
- 3
- Issue
- 4
- Pages
- 259-267
- ISSN
- 2352-3727 (ISSN-L)
- 2352-3735
- PMC
- PMC5676768
- OpenAlex
- W2767198233
- Cited by
- 78
- References
- 23
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 23 · 2023: 14 · 2022: 9 · 2021: 7 · 2020: 7 · 2019: 7
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Bladder Cancer (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Surgery › Urinary and Genital Oncology Studies
- Keywords
- tertiary lymphoid structures, bladder urothelial carcinoma, tumor stage, muscle-invasive bladder cancer, non-muscle-invasive bladder cancer, germinal center, B cell response, tumor immune microenvironment, high endothelial venules, follicular dendritic cells, tumor progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer. https://app.cochat.ai/papers/10.3233/blc-170120
- The paper
- Koti, M., Xu, A. S., Ren, K. Y. M., Visram, K., Ren, R., Berman, D. M., & Siemens, D. R. (2017). Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer. Bladder Cancer. https://doi.org/10.3233/blc-170120
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.